Michael Scolaro

Michael Scolaro

Sep 08, 2017

Group 6 Copy 160
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can Data Management Tools Improve Research Efficiency and Reproducibility?

Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

How do you know a surgeon in training is ready to operate independently?

I am trying to find a cheap, easy and reliable way to grade the skill of surgeons in training. Experts can judge...

Early-Stage Drug Discovery for Chagas' Disease

An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan...

Backer Badge Funded